EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MOGAD-related epilepsy: a systematic characterization of age-dependent clinical, fluid, imaging and neurophysiological features

Martina Rubin, Gianni Cutillo, Vittorio Viti, Monica Margoni, Paolo Preziosa, Chiara Zanetta, Anna Bellini, Lucia Moiola, Giovanna Franca Fanelli, Maria Assunta Rocca, Massimo Filippi

Journal of Neurology · 2025

DOI: 10.1007/s00415-025-13245-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurology, 2025. Verfasst von Martina Rubin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Demyelinating Autoimmune Diseases, CNS, Epilepsy, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare central nervous system (CNS) demyelinating disease presenting heterogeneously across lifespan. Although frequent, epilepsy remains a poorly characterized MOGAD-associated manifestation. METHODS: To describe age-related clinical, fluid, imaging, and neurophysiological features in MOGAD patients with epilepsy, we systematically reviewed online repositories up to April 2025, identifying 178 eligible studies. RESULTS: A total of 2487 MOGAD patients were included from clinical studies, and of 337 from case reports/series, 140 with adult-onset and 197 with pediatric-onset disease. Seizures prevalence was 30.6% (95% confidence interval [95%CI] = 28%; 33.3%) in pediatric-onset and 7% (95%CI = 4.1%; 11.2%) in adult-onset cohorts. Pediatric-onset patients were significantly more likely to be female (p = 0.003). Cortical encephalitis was the most common presentation in both age groups, followed by acute demyelinating encephalomyelitis in pediatric-onset and acute demyelinating syndrome in adult-onset patients. In both groups, epileptic manifestations predominantly occurred at disease onset. Pediatric-onset patients were more likely to experience status epilepticus (p = 0.005) and encephalopathy (p = 0.002), whereas adult-onset exhibited higher frequency of cerebrospinal fluid pleocytosis (p < 0.001). Co-positivity with antibodies related to other encephalitides was present in 37.3% of patients, most commonly with anti-N-methyl-D-aspartate receptor (anti-NMDAR) IgG (88.3%), showing no age-dependent differences. No significant age-related differences were observed in leptomeningeal enhancement. Adult-onset patients more frequently showed parietal lobe involvement (p = 0.018) and fewer temporal lobe lesions (p = 0.004) compared to pediatric-onset. Despite comparable use of immunotherapy and anti-seizure medications across groups, chronic epilepsy was more prevalent among pediatric-onset patients (p < 0.001). CONCLUSIONS: Epilepsy is a relevant MOGAD-associated condition with a risk of chronic persistence. Prospective studies are warranted to establish an age-specific therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Demyelinating Autoimmune Diseases, CNSEpilepsyMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAdolescentAdultAgedChildChild, PreschoolFemaleHumansMaleMiddle AgedYoung AdultAge FactorsAge of OnsetAutoantibodies

Stichwörter der Autor:innen

ADEMAnti-seizure medicationCortical encephalitisEpilepsyImmunosuppressive treatmentMOGADPediatricSeizures

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.

Zitieren

APA

Rubin, M., Cutillo, G., Viti, V., Margoni, M., Preziosa, P., Zanetta, C., Bellini, A., Moiola, L., Fanelli, G. F., Rocca, M. A., & Filippi, M. (2025). MOGAD-related epilepsy: a systematic characterization of age-dependent clinical, fluid, imaging and neurophysiological features. Journal of Neurology. https://doi.org/10.1007/s00415-025-13245-3

Vancouver

Rubin M, Cutillo G, Viti V, Margoni M, Preziosa P, Zanetta C, et al. MOGAD-related epilepsy: a systematic characterization of age-dependent clinical, fluid, imaging and neurophysiological features. Journal of Neurology. 2025. doi:10.1007/s00415-025-13245-3

BibTeX
@article{Rubin2025,
  author = {Rubin, Martina and Cutillo, Gianni and Viti, Vittorio and Margoni, Monica and Preziosa, Paolo and Zanetta, Chiara and Bellini, Anna and Moiola, Lucia and Fanelli, Giovanna Franca and Rocca, Maria Assunta and Filippi, Massimo},
  title = {MOGAD-related epilepsy: a systematic characterization of age-dependent clinical, fluid, imaging and neurophysiological features},
  journal = {Journal of Neurology},
  year = {2025},
  doi = {10.1007/s00415-025-13245-3}
}
Kostenlos starten →